Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Disability-Adjusted Life Years, Years Lived With Disability, and Years of Life Lost of Diseases Among Children and Adolescents in National and Subnational Levels of Iran, 1990–2021: A Systematic Analysis for the Global Burden of Disease 2021
Fatemeh Nabavizadeh Rafsanjani
Fatemeh Nabavizadeh Rafsanjani

Professor of Physiology

Department Physiology

School of Medicine

Electrophysiology Research Center

Tehran University of Medical Sciences

All Documents
1. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
2. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
7. Berberine and Lung Cancer: From Pure Form to Its Nanoformulations, Asia-Pacific Journal of Clinical Oncology (2024)